Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
YI ›
YIRVADA
Trademark search for:
YIRVADA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-08-27 — Application filed
2014-08-30 — Application filed
2014-09-09 — Application filed
2014-09-28 — Final disposition recorded
2014-09-28 — Final disposition recorded
2014-09-28 — Assigned to examiner
2014-09-28 — Final disposition recorded
2014-09-29 — Examiners amendment -written
2014-09-29 — Approved for pub - principal register
2014-09-29 — Examiners amendment e-mailed
2014-09-29 — Notification of examiners amendment e-mailed
2014-09-29 — Examiner's amendment entered
2014-10-16 — Assigned to lie
2014-10-16 — Law office publication review completed
2014-10-20 — Attorney/dom.rep.revoked and/or appointed
2014-10-20 — Teas revoke/app/change addr of atty/dom rep received
2014-10-29 — Notification of notice of publication e-mailed
2014-11-18 — Published for opposition
2014-11-18 — Official gazette publication confirmation e-mailed
2014-12-17 — Extension of time to oppose received
2015-04-17 — Teas change of owner address received
2015-04-17 — Applicant/correspondence changes (non-responsive) entered
2015-05-15 — Application abandoned
2015-05-18 — Application abandoned
2015-05-18 — Application abandoned
2015-05-18 — Final status recorded
Owner Information
Intarcia Therapeutics, Inc.
Boston , MA
Intarcia Therapeutics, Inc.
Boston , MA
Correspondent
Janet L. Cullum Cooley LLP 1299 Pennsylvania Ave., NW Suite 700 Washington, DC 20004
Filing Details
Filing Date:
2014-08-27
Status Date:
2015-05-18
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.